BioCorRx (BICX) Non Operating Income (2015 - 2026)
BioCorRx's (BICX) quarterly Non Operating Income came in at $96108.0 in Q1 2026, up 11.52% year-on-year from $86182.0 in Q1 2025, and up 52.63% quarter-over-quarter from $62967.0 in Q4 2025.
BioCorRx (BICX) Non Operating Income (2015 - 2026) Analysis & Trends
BioCorRx has disclosed Non Operating Income across 12 years of filings, most recently posting $96108.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $96108.0, up 11.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 333.27% YoY), and the FY2025 annual result was $1.3 million, up 1576.48% from the prior year.
- Non Operating Income came in at $96108.0 for Q1 2026 at BioCorRx, up from $62967.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $954000.0 in Q3 2025 to a low of -$268771.0 in Q1 2024.
- The 5-year median for Non Operating Income is $62967.0 (2025), against an average of $87339.6.
- Across the five-year window, Non Operating Income soared 3807.1% in 2022 and sank 741.06% in 2023, its largest moves.
- BioCorRx's Non Operating Income stood at $22821.0 in 2022, then tumbled by 741.06% to -$146297.0 in 2023, then advanced by 29.67% to -$102893.0 in 2024, then soared by 161.2% to $62967.0 in 2025, then surged by 52.63% to $96108.0 in 2026.
- The last three Non Operating Income figures came in at $96108.0 (Q1 2026), $62967.0 (Q4 2025), and $954000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 41.00 Mn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 4.47 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 18.70 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | -885,000.00 |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 3.39 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | - |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | -1,000.00 |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 125,000.00 |
| 10 | BioCorRx | - | - | 189,355.00 | 96,108.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96,108.00 |
| Dec 31, 2025 | 62,967.00 |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 36,644.00 |
| Mar 31, 2025 | 86,182.00 |
| Dec 31, 2024 | -102,893.00 |
| Sep 30, 2024 | 146,711.00 |
| Jun 30, 2024 | 135,356.00 |
| Mar 31, 2024 | -268,771.00 |
| Dec 31, 2023 | -146,297.00 |
| Sep 30, 2023 | 94,520.00 |
| Jun 30, 2023 | 23,354.00 |
| Mar 31, 2023 | 45,729.00 |
| Dec 31, 2022 | 22,821.00 |
| Sep 30, 2022 | 78,122.00 |
| Jun 30, 2022 | 40,537.00 |
| Mar 31, 2022 | 179,683.00 |
| Dec 31, 2021 | 131,403.00 |
| Sep 30, 2021 | 271,412.00 |
| Jun 30, 2021 | -98,499.00 |